Frontline Venetoclax/Obinutuzumab Approved in ... - CLL Support

CLL Support

22,367 members38,474 posts

Frontline Venetoclax/Obinutuzumab Approved in Europe for CLL

AussieNeil profile image
AussieNeilAdministrator
8 Replies

In some welcome good news, "The European Commission has approved a fixed-dose combination of venetoclax (Venclexta) and obinutuzumab (Gazyva) for the treatment of patients with previously untreated chronic lymphocytic leukemia (CLL)"

onclive.com/web-exclusives/...

Neil

Written by
AussieNeil profile image
AussieNeil
Administrator
To view profiles and participate in discussions please or .
Read more about...
8 Replies
seelel profile image
seelel

That's probably good news for Australia as well, because in time, we seem to follow once the US and Europe have approved a treatment.

Ironj profile image
Ironj

Little off topic but I would love to put a roof on that building.

UK-Sparky profile image
UK-Sparky

Hopefully applies to UK as well

camper2 profile image
camper2

Oh that’s such good news for me (provided the UK follows suit) the numbers look good and it will avoid me having yet another round of chemo with C+O. I might be CLL ‘treatment naive’ but I have had 3 lots of chemo already. I have been told I am likely to be in treatment by the end of this year.

Because this Forum pushes us to see a CLL expert (thank you for that!) I have asked for a 2nd opinion on my treatment options at Barts (no appointment as yet) given my comorbidities and this post gives me ammunition to take to the discussion.

Thank you AussieNeil!

t213jbl profile image
t213jbl

That is good news. Is there a link to the actual European Decision rather than press releases or external sites?

AussieNeil profile image
AussieNeilAdministrator in reply to t213jbl

"On 30 January 2020, the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending a change to the terms of the marketing authorisation for the medicinal product venetoclax (Venclyxto).

:

Venclyxto in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (CLL). "

esmo.org/oncology-news/ema-...

t213jbl profile image
t213jbl

Hi

Thanks

Yes I have seen that, and understand that it is a recommendation to change the terms etc. It is not confirmation of the EU decision made (I think) 9th March or thereabouts.

I will do some searching

Etoile7 profile image
Etoile7

This is EXCELLENT news...just too bad that rigj’y now with Covid is not the time I would start a treatment with 52% chances of neutropenia... :(

You may also like...

FDA Frontline Approval of Venetoclax and Obinituzumab in the USA

ople-with-previously-untreated-chronic-lymphocytic-leukemia-cll-or-small-lymphocytic-lymphoma-sll/...

venetoclax and obinutuzumab treatment for cll

months treatment for cll tp53 mutated, I now have 2 monthly checks and my lymphocytes are low, is...

Venetoclax plus obinutuzumab - the first chemotherapy-free, fixed-duration first line CLL treatment approved by Health Canada

combination regimen approved by Health Canada for patients with previously untreated chronic...

Obinutuzumab and Venetoclax

had confirmed that Obinutuzumab and Venetoclax had been approved in UK as a frontline treatment. I...

Obinutuzumab + venetoclax

Scheduled to start treatment end of the month to have CLL under control.Felt fine otherwise and...